[HTML][HTML] The effect of probiotics on immune responses and their therapeutic application: a new treatment option for multiple sclerosis

B Hashemi, M Abdollahi, S Abbaspour-Aghdam… - Biomedicine & …, 2023 - Elsevier
Multiple sclerosis (MS) is known as a chronic inflammatory disease (CID) that affects the
central nervous system and leads to nerve demyelination. However, the exact cause of MS …

Effects of different dietary interventions in multiple sclerosis: A systematic review of evidence from 2018 to 2022

B Atabilen, Y Akdevelioğlu - Nutritional neuroscience, 2023 - Taylor & Francis
Background Nutrition is an important risk factor for both Multiple sclerosis (MS) development
and post-diagnosis disease prognosis. However, it is important to evaluate the diet as a …

Body mass index, interleukin-6 signaling and multiple sclerosis: a mendelian randomization study

M Vandebergh, S Becelaere… - Frontiers in …, 2022 - frontiersin.org
Objectives We explored whether genetically predicted increased body mass index (BMI)
modulates multiple sclerosis (MS) risk through interleukin-6 (IL-6) signaling. Methods We …

Emerging biomarkers of multiple sclerosis in the blood and the CSF: a focus on neurofilaments and therapeutic considerations

T Biernacki, Z Kokas, D Sandi, J Füvesi… - International Journal of …, 2022 - mdpi.com
Introduction: Multiple Sclerosis (MS) is the most common immune-mediated chronic
neurodegenerative disease of the central nervous system (CNS) affecting young people …

The second brain: The connection between gut microbiota composition and multiple sclerosis

M Farshbafnadi, E Agah, N Rezaei - Journal of neuroimmunology, 2021 - Elsevier
Gut microbiota composition may affect the central nervous system (CNS) and immune
function. Several studies have recently examined the possible link between gut microbiota …

Pediatric multiple sclerosis: an update

S Otallah, B Banwell - Current Neurology and Neuroscience Reports, 2018 - Springer
Abstract Purpose of Review Diagnostic criteria for pediatric-onset multiple sclerosis (POMS)
and related demyelinating disorders have been updated, neuroimaging studies have …

Metabolic Synergy between Human Symbionts Bacteroides and Methanobrevibacter

JL Catlett, S Carr, M Cashman, MD Smith… - Microbiology …, 2022 - Am Soc Microbiol
Trophic interactions between microbes are postulated to determine whether a host
microbiome is healthy or causes predisposition to disease. Two abundant taxa, the Gram …

[HTML][HTML] Abdominal obesity, chronic inflammation and the risk of non-alcoholic fatty liver disease

D Zhao, H Cui, Z Shao, L Cao - Annals of Hepatology, 2023 - Elsevier
Abstract Introduction and Objectives The purpose of this study was to evaluate the effect of
abdominal obesity and chronic inflammation on risk of non-alcoholic fatty liver disease …

Leptin levels are associated with multiple sclerosis risk

M Biström, J Hultdin, O Andersen… - Multiple Sclerosis …, 2021 - journals.sagepub.com
Background: Obesity early in life has been linked to increased risk of developing multiple
sclerosis (MS). Leptin and insulin are both associated with obesity, making them suitable …

UCHL1, besides leptin and fibronectin, also could be a sensitive marker of the relapsing–remitting type of multiple sclerosis

E Górska, M Tylicka, A Hermanowicz, E Matuszczak… - Scientific reports, 2023 - nature.com
Research on the markers of immunoregulatory response in multiple sclerosis (MS) is still of
great importance. The aim of our study was the evaluation of leptin, fibronectin, and UCHL1 …